Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00748059 · ClinicalTrials.gov registry record · Phase 1

The Pathophysiology of Orthostatic Hypotension

A Phase 1 study, sponsored by Vanderbilt University Medical Center.

Completed
Registry status
Phase 1
Development phase
10
Enrollment target

NCT00748059: Completed Phase 1 study, sponsored by Vanderbilt University Medical Center.

NCT00748059 is a Phase 1 study that has completed, run by Vanderbilt University Medical Center. The registered enrollment target is 10 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (83% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00748059, a Phase 1 study, has completed, sponsored by Vanderbilt University Medical Center.

COMPLETED
Registry status
Phase 1
Development phase
10 participants
Enrollment target

Study Summary

The purpose of this study is to determine the cause of low blood pressure in selective patients who have problems with their involuntary (autonomic) nervous system. These patients frequently have had symptoms throughout their life, and their disorder might have a genetic basis. The biochemical, physiological and pharmacological procedures in this study should help us define the problem and perhaps lead to more effective treatment.

Interventions

  • PROCEDURE QSweat
  • PROCEDURE Microneurography
  • PROCEDURE Standing or upright tilt
  • DEVICE neck cuff stimulation
  • DRUG phenylephrine,isoproterenol,nitroprusside,propranolol,edrophonium,atropine,tyramine

Trial Details

FieldValue
Enrollment Target 10 participants
Start Date 1996-12
Est. Completion 2020-12
Phase Phase 1

What the finished NCT00748059 record still lists

NCT00748059 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (83% lower).

The record links to 0 conditions, and to 5 interventions - of which QSweat is the first listed.

NCT00748059 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00748059 about?

NCT00748059 is a clinical study titled "The Pathophysiology of Orthostatic Hypotension". The purpose of this study is to determine the cause of low blood pressure in selective patients who have problems with their involuntary (autonomic) nervous system. These patients frequently have had symptoms throughout their life, and their disorder might have a genetic basis. The biochemical, phys...

What is the current status of trial NCT00748059?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 10 participants. The study started on 1996-12. Estimated completion is 2020-12.

What interventions are being tested in trial NCT00748059?

The interventions under investigation include: QSweat (PROCEDURE), Microneurography (PROCEDURE), Standing or upright tilt (PROCEDURE), neck cuff stimulation (DEVICE), phenylephrine,isoproterenol,nitroprusside,propranolol,edrophonium,atropine,tyramine (DRUG).

Who is sponsoring clinical trial NCT00748059?

This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00748059's enrollment target sits among peer trials

10 1913th of 2000 higher than 46 of 2,000 other Phase 1 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00623389 · 10 participants · NA

    Evaluation of an Advanced Lower Extremity Neuroprostheses

  • NCT01241864 · 10 participants · Phase 2

    Islet Transplantation in Type 1 Diabetic Kidney Allograft

  • NCT01293214 · 10 participants · NA

    Vascularized Composite Allotransplantation for Multiple Extremity Amputations

  • NCT01474148 · 10 participants · NA

    A Neuroprosthesis for Seated Posture and Balance

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00748059, the US trial registry maintained by the National Library of Medicine. NCT00748059 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.